January

Out with the old, in with the new for the European Respiratory Review Sergio Harari Eur Respir Rev 2017; 26: 160118
Screening for COPD: the gap between logic and evidence Alan Kaplan, Mike Thomas Eur Respir Rev 2017; 26: 160113
Personalised medicine in asthma: from curative to preventive medicine Laurent Guilleminault, Hakima Ouksel, Chantal Belleguic, Yannick Le Guen, Patrick Germaud, Emilie Desfleurs, Christophe Leroyer, Antoine Magnan Eur Respir Rev 2017; 26: 160010
Comorbidities in interstitial lung diseases George A. Margaritopoulos, Katerina M. Antoniou, Athol U. Wells Eur Respir Rev 2017; 26: 160027
Pre-operative screening for obstructive sleep apnoea Johan Verbraecken, Jan Hedner, Thomas Penzel Eur Respir Rev 2017; 26: 160012
Association between morning symptoms and physical activity in COPD: a systematic review Amanda R. van Buul, Marise J. Kasteleyn, Niels H. Chavannes, Christian Taube Eur Respir Rev 2017; 26: 160033
Immune reconstitution inflammatory syndrome associated with pulmonary pathogens Radha Gopal, Rekha R. Rapaka, Jay K. Kolls Eur Respir Rev 2017; 26: 160042
The effect of mTOR inhibitors on respiratory infections in lymphangioleiomyomatosis Andrew M. Courtwright, Hilary J. Goldberg, Elizabeth Petri Henske, Souheil El-Chemaly Eur Respir Rev 2017; 26: 160004
LABA/LAMA combination in COPD: a meta-analysis on the duration of treatment Luigino Calzetta, Paola Rogliani, Josuel Ora, Ermanno Puxeddu, Mario Cazzola, Maria Gabriella Matera Eur Respir Rev 2017; 26: 160043
Prediction models for exacerbations in patients with COPD Beniamino Guerra, Violeta Gaveikaite, Camilla Bianchi, Milo A. Puhan Eur Respir Rev 2017; 26: 160061
Pulmonary vascular and cardiac impairment in interstitial lung disease Marios Panagiotou, Alistair C. Church, Martin K. Johnson, Andrew J. Peacock Eur Respir Rev 2017; 26: 160128
Diagnosis of primary ciliary dyskinesia: potential options for resource-limited countries Nisreen Rumman, Claire Jackson, Samuel Collins, Patricia Goggin, Janice Coles, Jane S. Lucas Eur Respir Rev 2017; 26: 160058
Epoprostenol and pulmonary arterial hypertension: 20 years of clinical experience Olivier Sitbon, Anton Vonk Noordegraaf Eur Respir Rev 2017; 26: 160055
Procalcitonin to guide antibiotic administration in COPD exacerbations: a meta-analysis Alexander G. Mathioudakis, Victoria Chatzimavridou-Grigoriadou, Alexandru Corlateanu, Jørgen Vestbo Eur Respir Rev 2017; 26: 160073
Epithelial cell migration as a potential therapeutic target in early lung cancer Fraser R. Millar, Sam M. Janes, Adam Giangreco Eur Respir Rev 2017; 26: 160069
C-reactive protein level predicts mortality in COPD: a systematic review and meta-analysis Giovanni Leuzzi, Carlotta Galeone, Francesca Taverna, Paola Suatoni, Daniele Morelli, Ugo Pastorino Eur Respir Rev 2017; 26: 160070
A systematic review and meta-analysis of complementary and alternative medicine in asthma Charlotte M. Kohn, Priyamvada Paudyal Eur Respir Rev 2017; 26: 160092
What people with Down Syndrome can teach us about cardiopulmonary disease Kelley L. Colvin, Michael E. Yeager Eur Respir Rev 2017; 26: 160098
Oxygen therapy for interstitial lung disease: a systematic review Emily C. Bell, Narelle S. Cox, Nicole Goh, Ian Glaspole, Glen P. Westall, Alice Watson, Anne E. Holland Eur Respir Rev 2017; 26: 160080
Personalising airway clearance in chronic lung disease Maggie McIlwaine, Judy Bradley, J. Stuart Elborn, Fidelma Moran Eur Respir Rev 2017; 26: 160086
Diagnosis of chronic thromboembolic pulmonary hypertension Deepa Gopalan, Marion Delcroix, Matthias Held Eur Respir Rev 2017; 26: 160108
Pulmonary endarterectomy in the management of chronic thromboembolic pulmonary hypertension David Jenkins, Michael Madani, Elie Fadel, Andrea Maria D'Armini, Eckhard Mayer Eur Respir Rev 2017; 26: 160111
Acute high-altitude sickness Andrew M. Luks, Erik R. Swenson, Peter Bärtsch Eur Respir Rev 2017; 26: 160096
Exertional dyspnoea in interstitial lung diseases: the clinical utility of cardiopulmonary exercise testing Matteo Bonini, Giuseppe Fiorenzano Eur Respir Rev 2017; 26: 160099
“Recent advances in targeting the prostacyclin pathway in pulmonary arterial hypertension.” M. Lang, Sean P. Gaine Eur Respir Rev 2017; 26: 155067